<DOC>
	<DOCNO>NCT00004015</DOCNO>
	<brief_summary>RATIONALE : Boron neutron capture therapy may selectively kill tumor cell without harm normal tissue . PURPOSE : This phase I trial study side effect best dose boron neutron capture therapy follow surgery treat patient glioblastoma multiforme remove surgery .</brief_summary>
	<brief_title>Boron Neutron Capture Therapy Following Surgery Treating Patients With Glioblastoma Multiforme Removed During Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Determine systemic local toxicity borocaptate sodium boron neutron capture therapy ( BNCT ) follow craniotomy gross total resection patient glioblastoma multiforme . - Determine qualitative quantitative dose-limiting toxicity maximum tolerate dose regimen patient . - Determine maximum tolerate radiation dose BNCT cranial localization healthy tissue patient define condition . OUTLINE : This dose escalation , multicenter study . Within 6 week surgery , patient receive borocaptate sodium follow 12-18 hour later neutron irradiation . Treatment repeat daily 4 day . Cohorts 3-9 patient receive escalate dos neutron irradiation . The maximum tolerate dose define dose precede 3 patient experience dose limit toxicity . Patients follow weekly 4 week , monthly 2 month , every 6 week 15 month every 3 month thereafter . PROJECTED ACCRUAL : Approximately 30-36 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven glioblastoma multiforme conventional radiotherapy would little benefit Gross total resection tumor confirm postoperative MRI perform within 48 hour surgery Evaluable preoperative postoperative MRI film without contrast must available No prior brain malignancy No prior craniotomy except glioblastoma PATIENT CHARACTERISTICS : Age : 50 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin , SGOT , SGPT , alkaline phosphatase great 2.5 time normal unless cause reversible reaction antiseizure medication Renal : Blood urea nitrogen creatinine great 2.5 time upper limit normal Cardiovascular : No severe heart disease ( e.g. , congestive heart failure , angina pectoris ) Pulmonary : No severe dyspnea time diagnosis No severe obstructive restrictive lung disease Other : No concurrent malignant tumor No severe gastrointestinal disease active peptic ulcer disease No uncontrolled endocrine disease No serious mental disease , organic brain disease ( e.g. , preexist epilepsy serious aphasia ) , legally incapacitated patient PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy glioblastoma multiforme No concurrent biologic therapy Chemotherapy : No prior chemotherapy glioblastoma multiforme No concurrent chemotherapy Endocrine therapy : No prior endocrine therapy glioblastoma multiforme except corticosteroid No concurrent endocrine therapy Radiotherapy : See Disease Characteristics No prior radiotherapy glioblastoma multiforme No prior radiotherapy head neck No concurrent radiotherapy Surgery : See Disease Characteristics Prior stereotactic biopsy allow glioblastoma multiforme</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>